Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia

International Journal of Cancer

Volumn 139, Issue 2, 2016, Pages 281-290

  Sultana, Farhana ^a   English, Dallas R ^a,b   Simpson, Julie A ^a   Drennan, Kelly T ^c   Mullins, Robyn ^b   Brotherton, Julia M L ^a,c   Wrede, C David ^d,e   Heley, Stella ^c   Saville, Marion ^c,e   Gertig, Dorota M ^a,c,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c VICTORIAN CYTOLOGY SERVICE   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Victorian Cervical Cytology Registry Melbourne   (Australia)

Author keywords

HPV; never screened; RCT; self sampling; under screened

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; FEMALE; HIGH RISK POPULATION; HOME CARE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS; CLINICAL TRIAL; COMPLICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATIENT COMPLIANCE; PREVALENCE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SELF CARE; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADULT; AGED; AUSTRALIA; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PATIENT COMPLIANCE; PREVALENCE; SELF CARE; UTERINE CERVICAL NEOPLASMS;

EID: 84960335229     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30031     Document Type: Article

References (34)

1. Bos AB, Rebolj M, Habbema JD, et al., Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 2006; 119: 2372-5.
2. Victorian Cervical Cytology Registry (VCCR). Statistical Report. Victoria: 2013
3. Waller J, Bartoszek M, Marlow L, et al., Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 2009; 16: 199-204.
4. Sultana F, Mullins R, Murphy M, et al., Women's views on human papillomavirus self-sampling: focus groups to assess acceptability, invitation letters and a test kit in the Australian setting. Sex Health 2015; 12: 279-286.
5. (MSAC) MSAC. National Cervical Screening Program Renewal: Evidence Review. Canberra:Department of Health and Ageging; 2013
6. Schmeink CE, Bekkers RL, Massuger LF, et al., The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol 2011; 21: 139-53.
7. Snijders PJ, Verhoef VM, Arbyn M, et al., High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013; 132: 2223-36.
8. Arbyn M, Verdoodt F, Snijders PJ, et al., Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-Analysis. Lancet Oncol 2014; 15: 172-83.
9. Verdoodt F, Jentschke M, Hillemanns P, et al., Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-Analysis of randomised trials. Eur J Cancer 2015; 51: 2375-85
10. Szarewski A, Cadman L, Mesher D, et al., HPV self-sampling as an alternative strategy in non-Attenders for cervical screening-A randomised controlled trial. Br J Cancer 2011; 104: 915-20.
11. Virtanen A, Anttila A, Luostarinen T, et al., Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2011; 128: 2681-7.
12. Virtanen A, Nieminen P, Luostarinen T, et al., Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 2011; 20: 1960-9.
13. Giorgi Rossi P, Marsili LM, Camilloni L, et al., The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer 2011; 104: 248-54.
14. Wikstrom I, Lindell M, Sanner K, et al., Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer 2011; 105: 337-9.
15. Sancho-Garnier H, Tamalet C, Halfon P, et al., HPV self-sampling or the Pap-smear: A randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 2013; 133: 2681-7.
16. Gok M, Heideman DA, van Kemenade FJ, et al., HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. Bmj 2010; 340: c1040
17. Broberg G, Gyrd-Hansen D, Miao Jonasson J, et al., Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-Attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer 2014; 134: 2223-30.
18. Darlin L, Borgfeldt C, Forslund O, et al., Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-Attending women in organized cervical screening. J Clin Virol 2013; 58: 155-60.
19. Sultana F, English DR, Simpson JA, et al., Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia. BMC Cancer 2014; 14: 207.
20. Zwarenstein M, Treweek S, Gagnier JJ, et al., Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Bmj 2008; 337: a2390
21. Sultana F, Gertig DM, Wrede CD, et al., A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing. J Clin Virol 2015; 69: 210-3.
22. Australian Bureau of Statistics. Socio-Economic Indexes for Areas (SEIFA). Technical Paper Canberra: Australian Bureau of Statistics; 2011
23. Australian Institute of Health and Welfare AG. Cervical screening in Australia. Canberra: Australian Institute of Health and Welfare; 2012 -2013
24. Giorgi Rossi P, Fortunato C, Barbarino P, et al., Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter. Br J Cancer 2015; 112: 667-75.
25. Bosgraaf RP, Verhoef VM, Massuger LF, et al., Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening. Int J Cancer 2015; 136: 646-55.
26. Ronco G, Giorgi-Rossi P, Carozzi F, et al., Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
27. Bulkmans NW, Berkhof J, Rozendaal L, et al., Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-72.
28. Ronco G, Dillner J, Elfstrom KM, et al., Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014; 383: 524-32.
29. Cuzick J, Clavel C, Petry KU, et al., Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095-101.
30. Naucler P, Ryd W, Tornberg S, et al., Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007; 357: 1589-97.
31. Petignat P, Faltin DL, Bruchim I, et al., Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? a systematic review and meta-Analysis. Gynecol Oncol 2007; 105: 530-5.
32. Gok M, Heideman DA, van Kemenade FJ, et al., Offering self-sampling for human papillomavirus testing to non-Attendees of the cervical screening programme: characteristics of the responders. Eur J Cancer 2012; 48: 1799-808.
33. Bais AG, van Kemenade FJ, Berkhof J, et al., Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007; 120: 1505-10.
34. Canfell K, Caruana M, Brown JD, et al., Screening approaches for vaccinated population: compass trial Eurogin 2015 Sevila, Spain, 2015.